SGI Sows Incyte’s Linux Farm

Premium

While Incyte continues to reap a rich genomic harvest from its Linux farm, SGI has recently begun replanting copies of the Incyte Linux cluster in large companies around the world.

In late November, SGI announced that it had installed the first Linux cluster, along with its SGI Origin 2000 server, at Bristol-Myers Squibb. The pharmaceutical giant says it will use the system for gene and protein sequence analysis, transcriptional profiling, and proteomics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.